About Trimunocor

About company

Trimunocor is a dynamic spin-out formed to leverage innovations from the Medical Research Council and the University of Southampton focused on finding solutions to combat neonatal chronic lung disease. Our primary innovation centres around the development of natural anti-inflammatory and anti-microbial protein surfactant, protein D for a broad range of anti-inflammatory lung diseases. To deliver this innovation our team brings together world leading scientific talent, expansive clinical networks and renowned commercial experience together into a team that is poised to deliver exceptional results.